#51: TheMachine: U.S. Patent Office Upholds Key Human Embryonic Stem Cell Patent
Geron Corporation (Nasdaq:GERN) announced today that the U.S. Patent... |
February 28, 2008
09:33:53 AM |
#50: TheMachine: Start Licensing, Inc. Challenges Korean Company's Provision of Dog Cloning Services
Patent Licensee Will Take Legal Action to Protect Rights if Necessary... |
February 28, 2008
09:27:45 AM |
#49: TheMachine: Geron Ranked in Biotechnology Patent Scorecard Published in The Wall Street Journal
Geron Corporation (NASDAQ:GERN) was ranked number 5 of companies... |
February 28, 2008
09:27:08 AM |
#48: TheMachine: Geron Corporation to Present at BIO CEO & Investor Conference
Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma,... |
February 28, 2008
09:26:41 AM |
#47: TheMachine: Geron's Second U.S. Patent for Production of Pancreatic Islets from Human Embryonic Stem Cells Strengthens Company's Intellectual Property Position
Geron Corporation (Nasdaq:GERN) announced today that it has received... |
February 28, 2008
09:26:10 AM |
#46: NewsBot: Journal of Neuroimmunology Publishes Study Results Showing That Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Data Indicate Short Courses of Low-Dose Immunosuppression May be Sufficient to... |
November 20, 2007
11:36:15 PM |
#45: NewsBot: GERN News Geron Supports WARF's Claims to Human Embryonic Stem Cell Patents
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) supports the... |
April 2, 2007
06:39:00 PM |
#44: NewsBot: GERN News Geron Corporation Reports Fourth Quarter and Annual 2006 Financial Results and Highlights
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today... |
March 16, 2007
04:00:00 AM |
#43: NewsBot: GERN News Geron Grants License to Asia Biotech Corporation
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today... |
March 12, 2007
04:30:00 AM |
#42: NewsBot: GERN News Geron to Restate Financial Results of Prior Periods
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today... |
March 9, 2007
04:30:00 AM |
#41: NewsBot: GERN News Geron Corporation Announces Exercise of Warrants for $15.0 Million of Proceeds
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today... |
February 27, 2007
04:30:00 AM |
#40: NewsBot: GERN News Unique Structure of Geron's Telomerase Inhibitor Drug Promotes Anti-Tumor, Anti-Metastatic Activity in Lung Cancer Cells
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today... |
February 15, 2007
04:30:00 AM |
#39: NewsBot: GERN News Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today... |
January 17, 2007
04:30:00 AM |
#38: NewsBot: GERN News Geron's Telomerase Inhibitor Drug May Benefit Breast Cancer Patients Receiving Radiation Therapy
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today... |
December 19, 2006
04:30:00 AM |
#37: NewsBot: GERN News Geron Announces Direct Equity Issuance
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today... |
December 14, 2006
04:30:00 AM |
| 
| 
| 
| 
| 
| 
